Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinoma

Benzer Materyaller

• Nanoparticle albumin-bound paclitaxel combined with cisplatin as the first-line treatment for metastatic esophageal squamous cell carcinoma
  Yazar:: Shi, Yan, ve diğerleri
  Baskı/Yayın Bilgisi: (2013)
• A retrospective clinical study of comparing paclitaxel plus S-1 versus paclitaxel plus cisplatin as the first-line treatment for patients with advanced esophageal squamous cell carcinoma
  Yazar:: Wang, Hai-ying, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Paclitaxel plus cisplatin vs. 5-fluorouracil plus cisplatin as first-line treatment for patients with advanced squamous cell esophageal cancer
  Yazar:: Liu, Ying, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma
  Yazar:: Huang, Yan, ve diğerleri
  Baskı/Yayın Bilgisi: (2016)
• Superior Therapeutic Efficacy of Nanoparticle Albumin Bound Paclitaxel Over Cremophor-Bound Paclitaxel in Experimental Esophageal Adenocarcinoma
  Yazar:: Hassan, Md Sazzad, ve diğerleri
  Baskı/Yayın Bilgisi: (2018)